BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 33100967)

  • 1. Tau Protein and Its Role in Blood-Brain Barrier Dysfunction.
    Michalicova A; Majerova P; Kovac A
    Front Mol Neurosci; 2020; 13():570045. PubMed ID: 33100967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauopathies - Focus on Changes at the Neurovascular Unit.
    Michalicova A; Banks WA; Legath J; Kovac A
    Curr Alzheimer Res; 2017; 14(7):790-801. PubMed ID: 28164774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies.
    Majerova P; Michalicova A; Cente M; Hanes J; Vegh J; Kittel A; Kosikova N; Cigankova V; Mihaljevic S; Jadhav S; Kovac A
    PLoS One; 2019; 14(5):e0217216. PubMed ID: 31120951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
    Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA
    Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain capillaries in Alzheimer's disease.
    Baloyannis SJ
    Hell J Nucl Med; 2015; 18 Suppl 1():152. PubMed ID: 26665235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
    Laurent C; Buée L; Blum D
    Biomed J; 2018 Feb; 41(1):21-33. PubMed ID: 29673549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
    Canepa E; Fossati S
    Front Neurol; 2020; 11():573324. PubMed ID: 33488493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood-brain barrier in Alzheimer's disease.
    Zenaro E; Piacentino G; Constantin G
    Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer's Disease.
    Sarkar P; Banu S; Bhattacharya S; Bala A; Sur D
    Curr Diabetes Rev; 2023; 19(5):e130522204763. PubMed ID: 35570545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction.
    Takata F; Nakagawa S; Matsumoto J; Dohgu S
    Front Cell Neurosci; 2021; 15():661838. PubMed ID: 34588955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Tau on Neurotoxicity and Cerebral Vasculature Impairment Associated with Alzheimer's Disease.
    Rather MA; Khan A; Jahan S; Siddiqui AJ; Wang L
    Neuroscience; 2024 Jun; 552():1-13. PubMed ID: 38871021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
    Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
    J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood-brain barrier in health and chronic neurodegenerative disorders.
    Zlokovic BV
    Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies.
    Hanes J; Dobakova E; Majerova P
    Curr Pharm Des; 2020; 26(13):1448-1465. PubMed ID: 32178609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.
    Candelario-Jalil E; Dijkhuizen RM; Magnus T
    Stroke; 2022 May; 53(5):1473-1486. PubMed ID: 35387495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.